The efficacy of darbepoetin alfa for treating anemia, when administered intravenously once weekly: Hemodialysis patients (n=157) maintained on recombinant human erythropoietin were switched to darbepoetin alfa
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.